Alibaba to Pay $600M Over Allegations of Illegal Pharmaceutical Sales in the U.S.

[ad_1]

(MedPage Today) — The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals…

[ad_2]

Source link : https://www.medpagetoday.com/washington-watch/washington-watch/122026

Author :

Publish date : 2026-07-04 14:00:00

Copyright for syndicated content belongs to the linked Source.